E for Ecstasy by Nicholas Saunders
Appendix 1: Reference Section
- 24 Analgesic safety and efficacy of MDMA in modification of pain
and distress of end-stage cancer, Charles Grob et al.
- This is a proposal for a clinical investigation of the potential of
MDMA as an analgesic for cancer pain. It involves 24 subjects and takes
2 years to complete. It focuses on gathering preliminary data concerning
safety and tolerance, the drug's mechanism of action and its safety.
- End-stage pancreatic cancer patients have been selected as the most
suitable subjects. 24 subjects are needed, all with chronic pain as a result
of end-stage pancreatic cancer. 12 patients used as controls are identically
treated with placebos (to provide a double blind trial). All receive 4 sessions
separated by at least 2 weeks. Dosage is up to 2.3 mg/kg.
E is for Ecstasy by Nicholas Saunders (email@example.com)
HTMLized by Lamont Granquist (firstname.lastname@example.org)